SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-046512
Filing Date
2023-08-18
Accepted
2023-08-18 16:00:10
Documents
1
Period of Report
2023-08-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 20177
  Complete submission text file 0001209191-23-046512.txt   21624
Mailing Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304
Business Address 3160 PORTER DR. SUITE 250 PALO ALTO CA 94304 (650) 391-9740
BridgeBio Pharma, Inc. (Issuer) CIK: 0001743881 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3160 PORTER DR, STE 250 PALO ALTO CA 94304
Business Address
STEPHENSON BRIAN C (Reporting) CIK: 0001780030 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38959 | Film No.: 231185788